Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikofen vs sufentanil for patient-controlled analgesia after gynecological laparoscopic surgery
ChiCTR2600121930Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in postoperative pain (3 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Area under the curve of rest pain scores from 0 to 48 hours (AUC0-48h). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600121930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121930.